Mettler-Toledo International (NYSE:MTD – Free Report) had its target price trimmed by Citigroup from $1,700.00 to $1,550.00 in a report released on Friday,Benzinga reports. The firm currently has a buy rating on the medical instruments supplier’s stock.
A number of other research firms have also recently commented on MTD. Wall Street Zen upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating in a report on Saturday, February 14th. Morgan Stanley cut their target price on Mettler-Toledo International from $1,550.00 to $1,475.00 and set an “equal weight” rating on the stock in a research report on Tuesday, February 10th. Jefferies Financial Group raised Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their target price for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Barclays cut their target price on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating on the stock in a research report on Tuesday, April 14th. Seven research analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $1,447.08.
Read Our Latest Report on Mettler-Toledo International
Mettler-Toledo International Stock Performance
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its quarterly earnings data on Thursday, May 7th. The medical instruments supplier reported $8.91 EPS for the quarter, beating analysts’ consensus estimates of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The firm had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. During the same period in the prior year, the firm posted $8.19 earnings per share. The firm’s quarterly revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, equities research analysts forecast that Mettler-Toledo International will post 46.54 earnings per share for the current fiscal year.
Insider Transactions at Mettler-Toledo International
In other Mettler-Toledo International news, CFO Shawn Vadala sold 800 shares of the business’s stock in a transaction that occurred on Tuesday, February 10th. The stock was sold at an average price of $1,410.12, for a total value of $1,128,096.00. Following the sale, the chief financial officer owned 5,288 shares of the company’s stock, valued at $7,456,714.56. The trade was a 13.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.71% of the stock is currently owned by insiders.
Institutional Trading of Mettler-Toledo International
A number of institutional investors and hedge funds have recently added to or reduced their stakes in MTD. Vanguard Group Inc. increased its position in shares of Mettler-Toledo International by 1.3% during the third quarter. Vanguard Group Inc. now owns 2,591,173 shares of the medical instruments supplier’s stock worth $3,180,950,000 after acquiring an additional 34,466 shares during the period. Capital International Investors increased its position in shares of Mettler-Toledo International by 12.7% during the fourth quarter. Capital International Investors now owns 969,067 shares of the medical instruments supplier’s stock worth $1,351,064,000 after acquiring an additional 109,508 shares during the period. Alliancebernstein L.P. increased its position in shares of Mettler-Toledo International by 10.7% during the third quarter. Alliancebernstein L.P. now owns 793,927 shares of the medical instruments supplier’s stock worth $974,633,000 after acquiring an additional 76,478 shares during the period. T. Rowe Price Investment Management Inc. increased its position in shares of Mettler-Toledo International by 0.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 691,565 shares of the medical instruments supplier’s stock worth $964,174,000 after acquiring an additional 3,157 shares during the period. Finally, Geode Capital Management LLC increased its position in shares of Mettler-Toledo International by 2.4% during the fourth quarter. Geode Capital Management LLC now owns 597,448 shares of the medical instruments supplier’s stock worth $830,879,000 after acquiring an additional 14,106 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.
Trending Headlines about Mettler-Toledo International
Here are the key news stories impacting Mettler-Toledo International this week:
- Positive Sentiment: MTD beat first-quarter expectations, reporting adjusted EPS of $8.91 versus $8.70 expected and revenue of $947.1 million versus $943.1 million expected, with sales up 7.2% year over year. Mettler-Toledo International Inc. Reports First Quarter 2026 Results
- Positive Sentiment: Citigroup kept a Buy rating on MTD and still sees meaningful upside, even after lowering its price target to $1,550 from $1,700. Benzinga report on Citigroup price target cut
- Neutral Sentiment: The company reiterated full-year 2026 EPS guidance of $46.30 to $46.95, which is roughly in line with consensus, but did not provide a notable upside surprise. Mettler-Toledo International Inc. Reports First Quarter 2026 Results
- Negative Sentiment: Second-quarter EPS guidance of $10.70 to $10.85 came in below the Street’s estimate of $10.96, likely weighing on the stock despite the earnings beat. Mettler-Toledo International Inc. Reports First Quarter 2026 Results
About Mettler-Toledo International
Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.
The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.
See Also
- Five stocks we like better than Mettler-Toledo International
- Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum
- Quantum Earnings Season Is Ramping Up—What to Watch From 2 Major Players
- Flutter Sees Post-Earnings Boost as FanDuel Shows Signs of Recovery
- 3 Healthcare Stocks Set to Benefit From the One Big Beautiful Bill
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
